[New topical treatment of atopic dermatitis].
Topical inhibitors of calcineurin--tacrolimus and pimecrolimus have recently been approved in the treatment of atopic dermatitis. These are the first topical immunosuppressants other than glucocorticosteroids, awaited in dermatology since approximately 50 years. Both medications present similar mechanism of action, good therapeutic and safety profiles and should be considered as important factors in the treatment of atopic dermatitis.
Czarnecka-Operacz
Magdalena
M
Katedra i Klinika Dermatologii oraz Ośrodek Diagnostyki Chorób Alergicznych Akademii Medycznej w Poznaniu.
Silny
Wojciech
W
D003876:Dermatitis, Atopic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016559:Tacrolimus